[HTML][HTML] What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?

JC Davin, IJ Ten Berge, JJ Weening - Kidney international, 2001 - Elsevier
What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?
Henoch-Schönlein purpura nephritis (HSPN) and IgA nephropathy (IgAN) are considered to …

A new vision of IgA nephropathy: the missing link

F Sallustio, C Curci, V Di Leo, A Gallone… - International journal of …, 2019 - mdpi.com
IgA Nephropathy (IgAN) is a primary glomerulonephritis problem worldwide that develops
mainly in the 2nd and 3rd decade of life and reaches end-stage kidney disease after 20 …

Elevated levels of miR‐146a and miR‐155 in kidney biopsy and urine from patients with IgA nephropathy

G Wang, BCH Kwan, FMM Lai, KM Chow… - Disease …, 2011 - Wiley Online Library
Background: Previous studies suggested miR‐146a and miR‐155 play important roles in
innate and adaptive immune responses. We studied intra‐renal and urinary levels of miR …

HIV-associated immune-mediated renal disease

PL Kimmel, TM Phillips, A Ferreira-Centeno… - Kidney international, 1993 - Elsevier
HIV-associated immune-mediated renal disease. Although focal glomerulosclerosis is the
most common renal disease, other proliferative glomerulonephritides are encountered in …

High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schonlein purpura

G Rostoker, D Desvaux-Belghiti, Y Pilatte… - Annals of internal …, 1994 - acpjournals.org
Objective: To determine if polyvalent IgG is promising therapy for severe IgA nephropathy.
Design: Open prospective cohort study. Setting: Referral nephrology unit. Patients: 11 adult …

Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy

J Wang, RA Anders, Q Wu, D Peng… - The Journal of …, 2004 - Am Soc Clin Investig
Whether and how T cells contribute to the pathogenesis of immunoglobulin A nephropathy
(IgAN) has not been well defined. Here, we explore a murine model that spontaneously …

Growth factors in glomerulonephritis

HE Abboud - Kidney international, 1993 - Elsevier
Discussion DR. HANNA E. ABBOUD (Professor and Chief, Division of Nephrology, The
University of Texas Health Science Center, and Staff Physician, Audie Murphy Veterans …

Down-regulation of core 1 β1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1

K Yamada, N Kobayashi, T Ikeda… - Nephrology Dialysis …, 2010 - academic.oup.com
Abstract Background. Patients with IgA nephropathy (IgAN) have an increased amount of
abnormally O-glycosylated IgA1 in circulation, in glomerular deposits and produced by …

Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy

J Nakata, Y Suzuki, H Suzuki, D Sato, T Kano… - PLoS …, 2014 - journals.plos.org
Background Recent studies have shown that galactose-deficient IgA1 (GdIgA1) has an
important role in the pathogenesis of IgA nephropathy (IgAN). Although emerging data …

IgA nephropathy: morphologic expression and pathogenesis

SN Emancipator - American journal of kidney diseases, 1994 - Elsevier
IMMUNOGLOBULIN A nephropathy (IgAN) is defined as glomerulonephritis (GN) in which
IgA is the predominant immunoglobulin deposited in the glomerulus. 1-5 In addition to …